Omeros Updates Phase 3 Zaltenibart PNH Clinical Trial
March 22, 2025
Advarra Unveils Oncology Research Pulse
March 12, 2025
Hyde Park Capital Advises VitalTech on Its Sale to CoachCare
March 12, 2025
